Integra LifeSciences | IART - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Abbott USD 52.13B 1.3B 2025-12
AtriCure USD 491.94M 15.43M 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
CONMED USD 1.03B 24.83M 2025-12
Cooper Companies USD 8.36B 124.7M 2025-12
Dexcom USD 2.75B 19.9M 2025-12
Edwards Lifesciences USD 10.34B 132.6M 2025-12
Globus Medical USD 4.57B 174.42M 2025-12
HeartBeam USD 2.6M 2.2M 2025-12
Insulet USD 1.52B 131.1M 2025-12
Integra LifeSciences USD 1.04B 5.89M 2025-12
Intuitive Surgical USD 17.47B 349.5M 2026-03
J&J USD 81.19B 358M 2026-03
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.58B 54.9M 2025-12
Orthofix International USD 450.04M 7.55M 2025-12
Smith & Nephew USD 5.54B 331M 2025-12
Stryker USD 21.78B 594M 2025-09
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
Zimmer Biomet Holdings USD 12.7B 68.3M 2025-12